Molina Healthcare (NYSE:MOH) Reaches New 1-Year High Following Analyst Upgrade

Posted by Brenda Bartman on Jul 16th, 2026

Molina Healthcare, Inc (NYSE:MOH – Get Free Report) hit a new 52-week high on Tuesday after Truist Financial raised their price target on the stock from $205.00 to $250.00. Truist Financial currently has a hold rating on the stock. Molina Healthcare traded as high as $243.77 and last traded at $243.34, with a volume of 981195 shares trading hands. The stock had previously closed at $233.31.

MOH has been the topic of a number of other research reports. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a report on Wednesday, April 29th. Morgan Stanley upped their price target on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Mizuho set a $215.00 price objective on Molina Healthcare in a research note on Monday, June 8th. Robert W. Baird lifted their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. Three investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $207.06.

Read Our Latest Stock Analysis on MOH

Insider Activity at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

Hedge funds have recently bought and sold shares of the company. ARGA Investment Management LP lifted its holdings in Molina Healthcare by 1.4% in the 1st quarter. ARGA Investment Management LP now owns 4,166 shares of the company’s stock valued at $555,000 after acquiring an additional 59 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Molina Healthcare by 23.8% during the 4th quarter. Blue Trust Inc. now owns 322 shares of the company’s stock valued at $56,000 after purchasing an additional 62 shares in the last quarter. Elevation Wealth Partners LLC grew its stake in shares of Molina Healthcare by 118.2% in the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after purchasing an additional 78 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Molina Healthcare by 64.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 232 shares of the company’s stock worth $40,000 after purchasing an additional 91 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Molina Healthcare by 0.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,668 shares of the company’s stock worth $2,616,000 after purchasing an additional 92 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Price Performance

The firm has a market capitalization of $12.16 billion, a P/E ratio of 69.07 and a beta of 0.74. The business’s fifty day moving average is $201.97 and its 200 day moving average is $174.74. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the firm posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Molina Healthcare Company Profile

(Get Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.